Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM (opens ClinicalTrials.gov)
- Sponsor
- University of California, San Diego
- Enrolment
- 120
- Started
- 2023-07-25
- Last update
- 2026-07-17
Conditions: Fibrosis, Liver, Type 2 Diabetes Mellitus in Obese, Non-Alcoholic Fatty Liver Disease
Interventions: Semaglutide, Placebo